Liver Cancer

5 videos · updated daily
50:58
Recruitment & Participants

Sickle Cell: Clinical Trials Discussion at Patient Day

Suzy Lowi, Senior Clinical Research Practitioner in the Non-Malignant Haematology Clinical Trials Unit at Imperial College Healthcare NHS Trust, presents and discusses clinical trials at a sickle cell patient day run with the NIHR.

West London HCC·Jul 2026
23:31
Results & Readouts

GI Cancer Trials: EMERALD-3, FIGHT-302, CIRCULATE, MATTERHORN

The Oncology Brothers podcast talks with Dr. Neena Vijayvergia of Fox Chase Cancer Center about gastrointestinal studies presented at ASCO 2026, including EMERALD-3 in liver cancer, FIGHT-302 in cholangiocarcinoma, CIRCULATE and MATTERHORN.

OncBrothers: Practice-Changing Cancer Discussions·Jun 2026
33:57
Recruitment & Participants

Sickle Cell Gene Therapy and Trials: Patient Session

Suzi Lowi, a clinical trials research nurse at Imperial College Healthcare NHS Trust, explains what is involved in gene therapy at a West London HCC sickle cell patient event, with audience questions.

West London HCC·Sep 2026
4:24
Recruitment & Participants

Looking At Several Ways for People to Find and Enroll in Hepatitis B and Hepatitis D Clinical Trials

Chari Cohen, President of the Hepatitis B Foundation looks at ways for people to find and enroll in HBV and HDV clinical trials and learn about new drugs not only for Hepatitis B and D but also for Liver Cancer.

ICE-HBV·Dec 2022
1:40
Science & Therapies

The Sound and the Fury: Clinical Trial Uses Sound Waves to Treat Liver Tumors

WPLG Local 10 reports from a South Florida hospital that in January 2022 became the first in the area to use a non-invasive technique to destroy liver tumors, in a clinical trial in Miami-Dade.

WPLG Local 10·Sep 2022
Educational content only — not medical or investment advice. Titles, descriptions and tags are brief summaries of what the source says; do not rely on them in place of watching the video. Videos are embedded from their original sources and remain the property of their owners. Read the full disclaimer.